{"schema_version":"secwatch.filing_event.v1","accession":"0001601485-24-000074","form_type":"8-K","ticker":"ELTX","cik":"0001601485","company_name":"Elicio Therapeutics, Inc.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.933270+00:00","generated_at":"2026-05-30T00:55:58.071436+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Elicio Therapeutics Q3 2024 net loss $18.8M, cash $26M; AMPLIFY-7P enrollment on track","bullets":["Net loss $18.8M ($1.39 per share) vs $10.7M ($1.27) YoY; includes $8.5M non-cash warrant liability change.","Cash and cash equivalents $26.0M as of Sept 30, 2024; operational changes expected to fund into Q2 2025.","AMPLIFY-7P Phase 2 randomized study enrollment completion expected Q4 2024; interim DFS analysis H1 2025.","SITC poster showed durable T cell responses and antigen spreading in KRAS mutant tumors; ESMO oral presentation in Dec 2024.","R&D expense $7.2M, G&A $3.1M; $1.5M grant and $20M convertible notes closed in Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001601485-24-000074","json":"https://secwatch.observer/filing/0001601485-24-000074.json","markdown":"https://secwatch.observer/filing/0001601485-24-000074.md","text":"https://secwatch.observer/filing/0001601485-24-000074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000074/0001601485-24-000074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000074/angn-20241113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:55:58.071436+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}